Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT02926534 |
Date of registration:
|
03/10/2016 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan
|
Scientific title:
|
A Cross-sectional Study of the Socio-demographic and Other Determinants of Chronic Obstructive Pulmonary Disease (COPD) Among Those Who Smoke, Quit Smoking and Never-smoking Cigarettes |
Date of first enrolment:
|
September 2016 |
Target sample size:
|
900 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02926534 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Kazakhstan
| | | | | | | |
Contacts
|
Name:
|
Almaz T Sharman, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Kazakhstan Academy of Preventive Medicine |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- =10 pack-year smoking history (for smokers and ex-smokers)
- less than 100 cigarettes in lifetime (for never-smokers)
- be able to provide informed consent
Exclusion Criteria:
- be pregnant
- has a fever (370C or higher) at the time of the visit and during the last two weeks
preceding the visit
- be legally incapable
- chronic infectious and non-infectious lung disease except asthma (eg, pulmonary
fibrosis, bronchiectasis, cystic fibrosis, tuberculosis, and others.)
- resection of at least one lobe (or performing procedures to reduce lung volume)
- any cancer and receiving a course of radiation and/or chemotherapy at the time of the
visit;
- suspected lung cancer (presence of significant lung neoplasm)
- presence of metal in the chest
- ophthalmic surgery within the last 12 months prior to the visit
- myocardial infarction or other form of acute or chronic coronary insufficiency,
cardiac arrhythmias diagnosed of at least 6 months prior to the visit
- myocardial infarction or other form of acute or chronic coronary insufficiency,
cardiac arrhythmias with which an individual regularly receives medication
- Severely elevated blood pressure (equal to or greater than a systolic 180 or diastolic
of 100)
- history of cerebrovascular accidents
- thoracic or abdominal surgery within the last 6 months
- contraindications to use salbutamol or its analogues
- CT scan or other research using ionizing radiation within the last 6 months
Age minimum:
35 Years
Age maximum:
59 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Chronic Obstructive Pulmonary Disease (COPD)
|
Primary Outcome(s)
|
Evidence of chronic obstructive pulmonary disease
[Time Frame: up to 1 week]
|
Secondary Outcome(s)
|
COPD CT score
[Time Frame: up to 2 weeks]
|
Presence of metabolic syndrome
[Time Frame: up to 1 week]
|
Comorbidities of COPD
[Time Frame: up to 1 week]
|
Results of 6-minute walking test
[Time Frame: up to 1 week]
|
10 year risk of fatal CVD
[Time Frame: up to 1 week]
|
Presence of an electrocardiogram abnormality
[Time Frame: up to 1 week]
|
Airflow obstruction through lung function test
[Time Frame: up to 1 week]
|
COPD assessment test (CAT) score
[Time Frame: up to 1 week]
|
Secondary ID(s)
|
IIS.PMI.2016.001
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|